SMS Pharmaceuticals is a Manufacturer/Innovator company operating in the pharmaceutical industry.
SMS Pharmaceuticals Limited is a leading publicly listed API/Intermediates manufacturer with USFDA, EUGMP (Germany), TGA and Japan PMDA qualified sites. The company started operations in 1990 and caters to leading generic and innovator firms. It has seven manufacturing facilities in and close to Hyderabad, India. A state-of-the-art R&D center with synthesis, analytical and scale-up facilities is located in Hyderabad. The company operates in the following major therapeutic segments: anti-ulcer, anti-fungal, anti-migraine, anti-hypertensive and antiretroviral.
Company type
Manufacturer/Innovator
Products and services
APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
SMS Pharmaceuticals, Plot No. 72, H. No. 8-2-334 & 4, Hyderabad, India, 500 096
